Pomalyst

Report
21 Pages
August 2018
Region: Global
Citeline
ID: 4775165

Drug Overview
Pomalyst (pomalidomide; Celgene) is an oral class I thalidomide analog, immunomodulatory drug with antineoplastic activity.

In vitro studies have shown that the drug acts through multiple mechanisms. Evidence suggests that in addition to anti-angiogenic effects, Pomalyst inhibits proliferation and induces apoptosis of hematopoietic tumor cells, and may have antineoplastic effects. Pomalyst also enhanced T cell- and natural killer cell-mediated immunity and inhibited production of pro-inflammatory cytokines by monocytes.

OVERVIEW

Drug Overview
Product Profiles
Pomalyst : Multiple myeloma

LIST OF FIGURES

Figure 1: Pomalyst for multiple myeloma – SWOT analysis
Figure 2: The authors drug assessment summary of Pomalyst for multiple myeloma
Figure 3: The authors drug assessment summary of Pomalyst for multiple myeloma
Figure 4: Pomalyst sales for multiple myeloma across the US, Japan, and five major EU markets, by country, 2017–26

LIST OF TABLES

Table 1: Pomalyst drug profile
Table 2: Pomalyst pivotal trial data in multiple myeloma
Table 3: Pomalyst late-phase trial data in multiple myeloma
Table 4: Pomalyst key ongoing clinical trials in multiple myeloma
Table 5: Pomalyst sales for multiple myeloma across the US, Japan, and five major EU markets, by country ($m), 2017–26
Table 6: Patients treated with Pomalyst across the US, Japan, and five major EU markets, by country, 2017–26

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€9636EUR$10,000USD£8,289GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€47216EUR$49,000USD£40,615GBP

Table of Contents

Related Topics

Related Reports

Multiple Myeloma Market Insight, Epidemiology And Market Forecast - 2032

Relapsing Refractory Multiple Myeloma - Pipeline Insight, 2024

Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Global Multiple Myeloma Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type (Active Multiple Myeloma and Smoldering Multiple Myeloma), By Drug Type, By Regional Outlook and Forecast, 2023-2029

LAMEA Multiple Myeloma Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type (Active Multiple Myeloma and Smoldering Multiple Myeloma), By Drug Type, By Country and Growth Forecast, 2023-2029